ANIX
Anixa Biosciences Inc
Pharmaceutical PreparationsNasdaqNon-accelerated filer<br>Smaller reporting company
Total Trades
32
Buys
30
Sells
1
Largest Trade
$100K–$500K
Insiders
4
Institutional Funds
55
Inst. Value
$1M+
Activist Filings
5
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Baskies Arnold M | Director | BUY | $15K–$50K | 10K | $3.04 | Jan 29, 2026 |
| KUMAR AMIT | CEO | BUY | $15K–$50K | 5K | $3.16 | Jul 31, 2025 |
| Baskies Arnold M | Director | BUY | $15K–$50K | 5K | $3.39 | Jul 21, 2025 |
| Titterton Lewis H jr | Director | BUY | $15K–$50K | 10K | $3.14 | Jul 15, 2025 |
| KUMAR AMIT | CEO | BUY | $15K–$50K | 5K | $3.15 | Jul 14, 2025 |
| KUMAR AMIT | CEO | BUY | $15K–$50K | 10K | $2.85 | Jun 5, 2025 |
| Baskies Arnold M | Director | BUY | $1K–$15K | 5K | $2.82 | Jan 29, 2025 |
| Titterton Lewis H jr | Director | BUY | $1K–$15K | 3K | $2.94 | Jan 27, 2025 |
| Titterton Lewis H jr | Director | BUY | $1K–$15K | 2K | $3.01 | Jan 23, 2025 |
| Titterton Lewis H jr | Director | BUY | $15K–$50K | 6K | $2.59 | Jan 22, 2025 |
| Titterton Lewis H jr | Director | BUY | $15K–$50K | 10K | $2.57 | Jan 17, 2025 |
| KUMAR AMIT | CEO | BUY | $50K–$100K | 43K | $2.23 | Jan 15, 2025 |
| Catelani Michael | President | BUY | $15K–$50K | 9K | $2.15 | Jan 15, 2025 |
| Titterton Lewis H jr | Director | BUY | $50K–$100K | 27K | $3.09 | Aug 1, 2024 |
| Titterton Lewis H jr | Director | BUY | $1K–$15K | 4K | $2.68 | Jun 18, 2024 |
| Titterton Lewis H jr | Director | BUY | $1K–$15K | 405 | $2.70 | Jun 14, 2024 |
| Titterton Lewis H jr | Director | BUY | $15K–$50K | 7K | $2.66 | Jun 12, 2024 |
| Titterton Lewis H jr | Director | BUY | $15K–$50K | 11K | $2.52 | Jun 10, 2024 |
| Catelani Michael | President | BUY | $15K–$50K | 6K | $2.40 | Jun 7, 2024 |
| KUMAR AMIT | CEO | BUY | $50K–$100K | 25K | $2.41 | Jun 7, 2024 |
| Titterton Lewis H jr | Director | BUY | $15K–$50K | 15K | $3.28 | Apr 10, 2024 |
| KUMAR AMIT | CEO | SELL | $15K–$50K | 12K | $3.57 | Jul 31, 2023 |
| KUMAR AMIT | CEO | EXERCISE | $100K–$500K | 40K | $2.58 | Jul 31, 2023 |
| Catelani Michael | President, COO & CFO | BUY | $15K–$50K | 6K | $3.64 | Jul 21, 2023 |
| Titterton Lewis H jr | Director | BUY | $15K–$50K | 10K | $2.79 | Apr 27, 2022 |
| Catelani Michael | President | BUY | $1K–$15K | 6K | $2.66 | Apr 22, 2022 |
| Catelani Michael | President | BUY | $1K–$15K | 3K | $2.53 | Apr 21, 2022 |
| Titterton Lewis H jr | Director | BUY | $15K–$50K | 5K | $3.28 | Jan 13, 2022 |
| Titterton Lewis H jr | Director | BUY | $1K–$15K | 2K | $3.20 | Jan 12, 2022 |
| Titterton Lewis H jr | Director | BUY | $15K–$50K | 6K | $3.08 | Jan 11, 2022 |
| Titterton Lewis H jr | Director | BUY | $15K–$50K | 11K | $3.08 | Jan 10, 2022 |
| KUMAR AMIT | CEO | BUY | $50K–$100K | 20K | $3.00 | Jan 7, 2022 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Dec 31, 2025 · 55 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| VANGUARD GROUP INC | 1.3M | $1M+ | SH |
| Laird Norton Wetherby Trust Company, LLC | 588K | $1M+ | SH |
| D.A. DAVIDSON & CO. | 539K | $1M+ | SH |
| UBS Group AG | 418K | $1M+ | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 286K | $500K+ | SH |
| MISSION WEALTH MANAGEMENT, LP | 207K | $500K+ | SH |
| STATE STREET CORP | 159K | $100K–$500K | SH |
| LPL Financial LLC | 90K | $100K–$500K | SH |
| GSA CAPITAL PARTNERS LLP | 82K | $100K–$500K | SH |
| Bank of New York Mellon Corp | 55K | $100K–$500K | SH |
| RENAISSANCE TECHNOLOGIES LLC | 54K | $100K–$500K | SH |
| Virtu Financial LLC | 52K | $100K–$500K | SH |
| CoreCap Advisors, LLC | 48K | $100K–$500K | SH |
| Westside Investment Management, Inc. | 44K | $100K–$500K | SH |
| ACADIAN ASSET MANAGEMENT LLC | 44K | $100K–$500K | SH |
| HighTower Advisors, LLC | 41K | $100K–$500K | SH |
| MARSHALL WACE, LLP | 41K | $100K–$500K | SH |
| Gemmer Asset Management LLC | 35K | $100K–$500K | SH |
| Point72 Asset Management, L.P. | 31K | $50K–$100K | SH |
| OMERS ADMINISTRATION Corp | 31K | $50K–$100K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13D/A · Jan 7, 2026
7.0%
2.5M shares
SC 13D/A · Jun 6, 2025
16.3%
6.2M shares
SC 13D/A · Jan 3, 2025
15.1%
5.7M shares
SC 13D · May 3, 2024
5.3%
1.8M shares
SC 13D/A · Jan 16, 2024
13.5%
4.9M shares